Topics

3/22/18

A total of 37 original research projects from aspiring physician-scientists were on display at the 2018 Medical Student Research Forum.

6/8/15
For-Robin, a company founded and led by a Kate Rittenhouse-Olson, PhD, will further study and develop a promising potential cancer treatment.
10/6/14
Research led by a student in UB’s Medical Scientist Training Program is featured on the cover of the world’s most frequently cited cancer journal.
8/21/14

Nearly 100 student-scientists from across the country showcased their original biomedical research during the 2014 Buffalo Summer Research Day.

11/11/13

With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.

10/25/13

Through her fledgling start-up firm, University at Buffalo researcher Kate Rittenhouse-Olson, PhD ’84, is turning a mouse antibody she created into a promising cancer-fighting therapy for humans.

8/30/13

More than 100 student scientists from across the country showcased their original research during this summer’s University at Buffalo Biomedical Research Day.

4/26/13

The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.

3/1/12

Kunle Odunsi, director of RPCI’s Center for Immunotherapy and UB professor of gynecology and obstetrics, is leading a phase 1 clinical trial of the dendritic cell vaccine.